AMP-activated protein kinase (AMPK) is an energy sensor that regulates cellular metabolism. Activation of AMPK in skeletal muscles, the liver, and adipose tissues results in a favorable metabolic milieu for preventing and treating
type 2 diabetes, i.e., decreased levels of circulating
glucose, plasma
lipids, and ectopic fat accumulation and enhanced
insulin sensitivity.
Osthole was extracted from a Chinese herbal medicine, and we found that it had
glucose lowering activity in our previous study. However, the detailed
glucose lowering mechanisms of
osthole are still unclear. In this study, we used skeletal muscle cells to examine the underlying molecular mechanisms of
osthole's
glucose lowering activity. A Western blot analysis revealed that
osthole significantly induced phosphorylation of AMPK and
acetyl-CoA carboxylase (ACC). Next, we found that
osthole significantly increased the level of translocation of
glucose transporter 4 (GLUT4) to plasma membranes and
glucose uptake in a dose-dependent manner.
Osthole-induced
glucose uptake was reversed by treatment with Compound C, an AMPK inhibitor, suggesting that
osthole-induced
glucose uptake was mediated in an AMPK-dependent manner. The increase in the
AMP:
ATP ratio was involved in
osthole's activation of AMPK. Finally, we found that
osthole counteracted
hyperglycemia in mice with
streptozotocin-induced diabetes. These results suggest that the increase in the
AMP:
ATP ratio by
osthole triggered activation of the AMPK signaling pathway and led to increases in plasma membrane GLUT4 content and
glucose uptake level. Therefore,
osthole might have potential as an
antidiabetic agent for treating diabetes.